Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Oral Etoposide for Relapsed/Progressed AIDS-Related Kaposi's Sarcoma
NCT00000807Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
etoposide
Beyond the preview
Go deeper on NCT00000807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000807.